In Sherryl Broverman’s AIDS/Emerging Diseases class students often begin the course expecting to learn about the worldwide pandemic.
Part 2 in a series on global health. By Anthony So. In the late 1990s, one of my early missions for The Rockefeller Foundation took me to Khayelitsha, a poor township in South Africa. Its corrugated iron shacks stood in sharp contrast to the waterfront of neighboring Cape Town.
David Katz, professor at the Pratt School of Engineering at Duke, has developed a computer tool that could improve the design of topical microbicides now under development.
A 28-member team of health care professionals from Duke University Medical Center is carrying nine tons of surplus medical equipment and donated supplies to the 1500-bed New Mulago Hospital in Kampala, Uganda. Mulago Hospital staff will be trained to use and maintain the new equipment then surgeons from both countries will join in conducting a number of brain and spinal surgeries.
Andy Cunningham, a Duke student, blogs from Muhuru Bay in Kenya, where he spent the summer helping to prepare for the opening of a boarding school for girls. He was part of a team funded by DukeEngage.
A Duke Neurosurgery team led by Dr. Michael Haglund took more than 6 tons of surplus equipment to New Mulago Hospital, changing the face of neurosurgery in Kampala, Uganda.
Michael Merson writes on “Harnessing the passion for global health at Duke” in the Duke University Chronicle.
An international team of researchers has identified three gene variants in the DNA of 486 people infected with HIV that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS. The researchers expect the new findings to aid the search for an HIV vaccine that would work by boosting the protective effects of one or more of these genes, and help the body’s own immune system overcome an infection. It took the international genetics team, called EuroCHAVI, pooling their cohorts of carefully selected patients and using the latest in genome-wide screening technology, 18 months to discover the three genes, that together greatly increase our knowledge of why patients differ in how well they can control the virus that causes AIDS.